Shares of Aurora Cannabis Inc. ACB shed 1.40% to $6.33 Wednesday, on what proved to be an all-around mixed trading session ...

Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, in conjunction with MedReleaf Australia, recently removed the ...

Aurora Cannabis Inc. (TSE:ACB – Get Free Report) has earned an average recommendation of “Moderate Buy” from the five brokerages that are currently covering the company, MarketBeat.com reports. Three ...

Aurora Cannabis (NASDAQ: ACB) surged 45% after reporting record earnings, boosting CGC, TLRY, and CRON stocks.

Aurora Cannabis Inc (TSX:ACB) is set to release its Q3 2025 earnings on Feb 5, 2025. The consensus estimate for Q3 2025 ...

As a leader in the medical cannabis space, Aurora Cannabis is enjoying premium margins. Read why I rate ACB stock a Strong ...

Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to loss of $0.20 per share a year ago.

Aurora Cannabis Inc. (NASDAQ:ACB – Get Free Report) saw a large growth in short interest in the month of January. As of January 15th, there was short interest totalling 4,520,000 shares, a growth of 5 ...

CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical ...

Aurora Cannabis Inc. shares T.ACB are trading up $2.00 at $7.28.

Aurora Cannabis Inc. closed 31.34% below its 52-week high of $9.35, which the company reached on April 30th.